Network Pharmacology Evaluation Method Guidance-Draft

查看全文 作　　者：Shao [1]Li;Yi-Tao [2]Chen;Qing-Yang [2]Ding;Jian-Ye [2]Dai;Xian-Chun [2]Duan;Yuan-Jia [2]Hu;Xin-Xing [2]Lai;Qing-Fei [2]Liu;Ming [2]Niu;Rong-Wu [2]Xiang;Zheng [2]Xiang;Hai-Yu [2]Xu;Xin [2]Wang;Hong-Jun [2]Yang;Kuo [2]Yang;Ming [2]Yang;Hai-Yang [2]Yu;Bo [2]Zhang;Peng [2]Zhang;Qian-Ru [2]Zhang;Hui-Hui [2]Zhao;Jing [2]Zhao 机构地区：[1]Institute for TCM-X,MOE Key Laboratory of Bioinformatics/Bioinformatics Division,BNRIST,Department of Automation,Tsinghua University,Beijing 100084,P.R.China;[2]不详 出　　处：《World Journal of Traditional Chinese Medicine》索引2021年第7卷第1期,共9页 摘　　要：Foreword Note:Some of the document contents may involve certain patents,the identification of which is not the responsibility of the institution that releases the document.Main drafting organizations:Tsinghua University,Specialty Committee of Network Pharmacology of World Federation of Chinese Medicine Societies(WFCMS). 关 键 词：DOCUMENT DRAFT INSTITUTION